MIR5093

Across TCGA pan-cancer cohorts, MIR5093 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR5093 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MIR5093 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR5093 expression acts as an unfavorable survival marker, although some lineages such as UCS and BRCA show a favorable association.

UCS, COAD, and KIRC are the cancer types where MIR5093 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	II,III,IV	0.743	0.311	.002	96	view →
COAD	DFS	Tertile	All	0.225	0.536	.001	57	view →
KIRC	DFS	Tertile	II,III,IV	0.293	0.676	.002	54	view →
MESO	OS	Tertile	All	0.092	0.559	.003	45	view →
BRCA	OS	Tertile	III,IV	0.714	0.478	<.001	42	view →
KIRP	DFS	Tertile	II,III,IV	0.185	0.792	.002	42	view →
LGG	OS	Median	All	0.635	0.412	<.001	31	view →
BLCA	DFS	Tertile	All	0.171	0.512	.002	18	view →
LUAD	OS	Tertile	III,IV	0.878	0.436	.014	18	view →
CESC	OS	Tertile	III,IV	0.167	0.657	.044	18	view →
STAD	DFS	Tertile	IV	0.520	0.250	.033	9	view →
THCA	DFS	Tertile	IV	0.491	0.856	.032	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR5093–UCS (DFS)

Open the UCS breakdown →